LON:AZN | Market Exclusive

Home Tags LON:AZN

AstraZeneca plc (LON:AZN) price target set to GBX 6,200 by Jefferies...

ME Staff - August 16, 2018 0

AstraZeneca plc (LON:AZN) price target set to GBX 4,840 by HSBC

ME Staff - August 15, 2018 0

AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays with...

ME Staff - August 10, 2018 0

AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by JPMorgan Chase...

ME Staff - August 7, 2018 0

AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Shore Capital

ME Staff - August 3, 2018 0

AstraZeneca plc (LON:AZN) price target set to GBX 4,080 by Goldman...

ME Staff - August 2, 2018 0

AstraZeneca plc (LON:AZN) price target set to GBX 5,630 by Kepler...

ME Staff - August 1, 2018 0

Analyst Activity – Deutsche Bank AG Lowers Its Price Target On...

ME Staff - August 3, 2017 0

Analyst Activity – Goldman Sachs Group, Inc. (The) Sets Its Price...

ME Staff - August 2, 2017 0

Analyst Activity – Jefferies Group LLC Lowers Its Price Target On...

ME Staff - August 1, 2017 0

1...678 9 Page 7 of 9

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

March 2, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

February 3, 2025

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

January 20, 2025

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

April 11, 2016

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

April 8, 2016

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

November 8, 2017

ABOUT US

Market Exclusive offers the latest financial news and analysis for selected US stocks and securities. We are an investor driven research platform where new investment ideas from a exclusively selected group of seasoned investment analysts and qualified members from various disciplines are able to deliver their investment thesis’ across various industries and sectors. Our burgeoning team is comprised of individuals with strong backgrounds from various disciplines and businesses. Our goal is to provide an exclusive forum for contributors and users to leverage the knowledge base in order to make smarter investing decisions. At Market Exclusive, we believe that quality information from experienced well seasoned contributors provide our members with an edge that allows them to make wise investment choices. Market Exclusive is not a registered investment broker/dealer. The content on this site is for informational purposes only. Additionally, the content on this site does not represent the views of Market Exclusive and is solely a representation of the authors who publish them. Before investing in any security you should do your own due diligence and consult with a registered broker or financial advisor.

Tag: LON:AZN

AstraZeneca plc (LON:AZN) price target set to GBX 6,200 by Jefferies...

AstraZeneca plc (LON:AZN) price target set to GBX 4,840 by HSBC

AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by Barclays with...

AstraZeneca plc (LON:AZN) had its Overweight rating reiterated by JPMorgan Chase...

AstraZeneca plc (LON:AZN) had its Hold rating reiterated by Shore Capital

AstraZeneca plc (LON:AZN) price target set to GBX 4,080 by Goldman...

AstraZeneca plc (LON:AZN) price target set to GBX 5,630 by Kepler...

Analyst Activity – Deutsche Bank AG Lowers Its Price Target On...

Analyst Activity – Goldman Sachs Group, Inc. (The) Sets Its Price...

Analyst Activity – Jefferies Group LLC Lowers Its Price Target On...

EDITOR PICKS

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

Weekly Roundup on the Cannabis Sector & Psychedelic Sector

POPULAR POSTS

Weekly Biotech Report covering – Opko Health Inc (NYSE:OPK) Intercept...

Facebook Inc – (NASDAQ:FB) Might Be Moving Away From Its...

Biotechnology Movers: Here’s Why Citius Pharmaceuticals Inc (NASDAQ:CTXR) Is Running Right...

POPULAR CATEGORY